FDA Clearance Tracker · P860004-S387
SynchroMed® Infusion System, Ascenda® Intrathecal Catheters
Last checked: Nov 20, 2026Latest source record: Sep 2, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Sep 2, 2022
Approved
Time to decision
206 days
Received Feb 8, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P860004-S387
- Device name
- SynchroMed® Infusion System, Ascenda® Intrathecal Catheters
- Applicant
- Medtronic, Inc.
- Applicant location
- Minneapolis, MN
- Received
- Feb 8, 2022
- Decided
- Sep 2, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P860004
Device type
- Device class
- Class III
- Specialty
- Hospital Medicine & Nursing
FDA's approval statement
As written in FDA's record.
Approval for a change in the formulation of the resin used in the plastic hub component (Styrene-Butadiene Copolymer), and replacement of the current Urethane Acrylate adhesive (Dymax 1136-M) with another Urethane Acrylate adhesive (Dymax 1405-M-UR-SC), which is used to attach the cannula to the hub.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
K262913 · Decided Sep 17, 2026 · 29 days after receipt
Device type: Stents, Drains And Dilators For The Biliary Ducts (FGE) · GI, Urology & Nephrology
K262735 · Decided Aug 28, 2026 · 28 days after receipt
Device type: Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) (MXD) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.